Streetbeat News

MURF

Murphy Canyon Acquisition Corp

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Several stocks experienced significant price movements in Friday's mid-day session. MicroAlgo Inc. (MLGO) shares jumped 74% after unveiling a new algorithm to boost research institutions' performance. Lifezone Metals Limited (LZM) reported a H1 loss of $16.77 per share but still gained 27.4%. Mondee Holdings, Inc. (MOND) approved a $30 million share repurchase program, causing its shares to rise by 20%. On the other hand, Neptune Wellness Solutions Inc. (NEPT) shares dipped 45.7% after announcing a $4.5 million public offering. Flux Power Holdings, Inc. (FLUX) fell 15.1% following weaker-than-expected quarterly sales.

Portfolio Pulse from Lisa Levin

September 22, 2023 | 6:22 pm

Murphy Canyon Acquisition Corp's shares are trading lower due to volatility following its business combination with Conduit Pharmaceuticals.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 2:15 pm

Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. (NASDAQ:MURF) have completed their previously announced business combination. Conduit will commence trading on September 25, 2023, under ticker symbol 'CDT' for its common stock and 'CDTTW' for its warrants on The Nasdaq Global Market and The Nasdaq Capital Market respectively. The pro forma enterprise value at the debut of trading will be approximately $720 million. MURF has changed its name to Conduit Pharmaceuticals Inc. and will begin trading under the new ticker symbols.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 1:05 pm

US stocks traded lower with the Dow Jones falling around 200 points. Darden Restaurants Inc reported better-than-expected earnings for its first quarter with sales growth of 11.6% YoY to $2.73 billion. Murphy Canyon Acquisition Corp. shares shot up 39% after stockholder approval of the proposed combination with Conduit Pharmaceuticals. Cisco Systems agreed to acquire Splunk for $157 per share in cash. Travere Therapeutics shares dropped 41% after announcing topline two-year confirmatory secondary endpoint results from its Phase 3 PROTECT Study. Seelos Therapeutics was down 38% after announcing a $4.5 million registered direct offering of common stock and warrants to purchase common stock.

Portfolio Pulse from Lisa Levin

September 21, 2023 | 6:30 pm

The article reports on the stock movements in Thursday's mid-day session. Notable gainers include MSP Recovery, Near Intelligence, Murphy Canyon Acquisition, TradeUP Acquisition, Neptune Wellness, Inspire Veterinary Partners, Splunk, Solowin Holdings, AgriFORCE Growing Systems, Movella Holdings, Safe & Green Holdings, The Dixie Group, Calliditas Therapeutics, Applied Molecular Transport, Ainos, and Exscientia. Notable losers include Travere Therapeutics, Seelos Therapeutics, QuantaSing Group, Cazoo Group, Cheche Group, Comera Life Sciences, Mondee Holdings, TKO Group Holdings, Opendoor Technologies, TransCode Therapeutics, LanzaTech Global, WM Technology, CF Acquisition, WW International, ZipRecruiter, 36Kr Holdings, Evotec, Avinger, fuboTV, Affirm Holdings, Charles River Laboratories, Elutia, and Broadcom.

Portfolio Pulse from Lisa Levin

September 21, 2023 | 5:16 pm

U.S. stocks traded lower with the Dow Jones falling around 150 points. FedEx Corp (FDX) shares gained over 4% after reporting better-than-expected earnings for Q1, despite sales missing estimates. Murphy Canyon Acquisition Corp. (MURF), Near Intelligence, Inc. (NIR), and Splunk Inc. (SPLK) saw significant gains. Travere Therapeutics, Inc. (TVTX), Cazoo Group Ltd (CZOO), and Seelos Therapeutics, Inc. (SEEL) experienced significant drops.

Portfolio Pulse from Lisa Levin

September 21, 2023 | 4:07 pm

Murphy Canyon Acquisition announced that its stockholders have approved the proposed combination with Conduit Pharmaceuticals Limited. This news led to an increase in the trading of Murphy Canyon Acquisition shares.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 12:32 pm

Murphy Canyon Acquisition has announced that its stockholders have approved the proposed combination with Conduit Pharmaceuticals. The deal is expected to close soon.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 9:44 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.